Keywords: تعاملات دارویی; Triazoles; Antifungal activity; Drug-drug interactions; Tetrazole; CYP3A4;
مقالات ISI تعاملات دارویی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تعاملات دارویی; Chimeric mice with humanized liver; Prediction; Drug metabolism; Pharmacokinetics; Metabolite profiles; Drug-drug interactions;
Keywords: تعاملات دارویی; Cancer-associated thrombosis; Anticoagulants; Pharmacokinetics; Drug-drug interactions; Risk assessment;
Keywords: تعاملات دارویی; Drug safety; Adverse drug reaction; Drug-drug interactions; Heterogeneous networks; Social network mining;
Keywords: تعاملات دارویی; drug-drug interactions; psychiatric disorders; psychopharmacology; ASA; aspirin; BDI; Beck Depression Inventory; BZD; benzodiazepine; CAD; coronary artery disease; CHD; coronary heart disease; CV; cardiovascular; CVD; cardiovascular disease; CYP; cytochro
Keywords: تعاملات دارویی; Acetaminophen; Drug-drug interactions; Diclofenac; Piroxicam; Cyclic voltammetry;
Keywords: تعاملات دارویی; Antinociception; Thermal nociception; Cannabinoid receptor agonist; mu opioid receptor agonist; Drug-drug interactions; Rats;
Keywords: تعاملات دارویی; ALT; alanine aminotransferase; AST; aspartate aminotransferase; ath; Arabidopsis thaliana; ATV; atorvastatin; BSO; l-buthionine-(S,R)-sulfoximine; BUN; blood urea nitrogen; Cd; cluster of differentiation; CPFX; ciprofloxacin; CPK; creatinine phosphokinase
Keywords: تعاملات دارویی; carbonyl reductase 1; tissue distribution; liver; intestine; kidney; LC-MS/MS; protein quantification; proteomics; CBR; carbonyl reductase; DDI; drug-drug interactions; DMF; dimethylformamide; fm; fraction metabolized; IDA; information-dependent acquisiti
Keywords: تعاملات دارویی; ICU; Intensive Care Unit; PICU; Pediatrics ICU; DDIs; Drug-drug interactions; pDDIs; potential Drug-Drug Interactions; ADRs; Adverse Drug Reactions; KTH; Khyber Teaching Hospital; IQR; Interquartile range; PCM; Protein Calorie Malnutrition; DM; Diabetes M
Keywords: تعاملات دارویی; Think time; Clinical decision support; Drug-drug interactions; Alert fatigue; Pre-post evaluation;
Keywords: تعاملات دارویی; CYP450; Metabolic clearance; Drug-drug interactions; Abiraterone; Enzalutamide; Prostate cancer;
Keywords: تعاملات دارویی; Adverse drug reactions; High-risk pregnancy; Prevalence; Maternal age; Methyldopa; Ferrous sulfate; Drug-drug interactions;
Keywords: تعاملات دارویی; EHR; electronic health record; UCD; user-centered design; DDI; drug-drug interactions; HIBA; Hospital Italiano de Buenos Aires; CPOE; computerized physician order entry; HIMSS; Healthcare Information and Management Systems Society; TD; traditional design;
Keywords: تعاملات دارویی; Drug-drug interactions; Intensive care unit; Prevalence; Interrater reliability; Adverse drug events;
Keywords: تعاملات دارویی; transporters; endogenous biomarkers; drug-drug interactions;
Keywords: تعاملات دارویی; Opioid; Cannabinoid; Drug-drug interactions; Drug discrimination; Monkeys
Keywords: تعاملات دارویی; TIA; transient ischemic attack; RCT; randomized controlled trials; MI; myocardial infarction; DAPT; dual antiplatelet therapy; PAR; protease-activated receptor; DDIs; drug-drug interactions; PD; pharmacodynamics; PK; pharmacokinetics; TX; thromboxane; AA;
Keywords: تعاملات دارویی; Drug-drug interactions; Conceptual modeling; Knowledge representation; Ontology; Natural language processing; Computational inference;
Keywords: تعاملات دارویی; Rheumatoid arthritis; Glucocorticoids; Prednisolone; Dose; Side effect; Drug-drug interactions;
Keywords: تعاملات دارویی; Bosentan; Perfluorinated analogues; Metabolic specificity; Phase I metabolism; HLM; Cl; Clearance; CYP; Cytochrome P450; DDI; drug-drug interactions; ERA; Endothelin Receptor Antagonist; ET-1; Endothelin 1; ETA; Endothelin receptor A; ETB; Endothelin rece
Keywords: تعاملات دارویی; Drug-drug interactions; Prevalence; Risk factors; Ethiopia; Prescription
Keywords: تعاملات دارویی; absorption; adverse drug reactions; drug-drug interactions; membrane permeability; tight junction; pharmacokinetics;
Keywords: تعاملات دارویی; HCV; hepatitis C; LT; liver transplantation; DDI; drug-drug interactions; DAAs; direct-acting antivirals; PegINF; peginterferon; RBV; ribavirin; MELD; model of end-stage liver disease; PI; protease inhibitor; PR; peginterferon plus ribavirin; SAEs; seriou
Keywords: تعاملات دارویی; Cytochrome; Drug-drug interactions; Glucuronidation; Pharmacogenetics; Pharmacokinetics; Statins
The impact of proton pump inhibitors on the pharmacokinetics of voriconazole in vitro and in vivo
Keywords: تعاملات دارویی; VRC; voriconazole; PPIs; proton pump inhibitors; LAN; lansoprazole; ESO; esomeprazol; OME; omeprazole; PAN; pantoprazole; ILA; ilaprazole; DDIs; drug-drug interactions; CYP; cytochrome P450; TDM; therapeutic drug monitoring; HLM; human liver microsomes; N
In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein
Keywords: تعاملات دارویی; BBB; blood-brain barrier; BCRP; Breast Cancer Resistance Protein; BSA; bovine serum albumin; DAD; diode-array detection; DBH; dopamine β-hydroxylase; DDIs; drug-drug interactions; DMSO; dimethyl sulfoxide; EMA; European Medicines Agency; HBSS; Hanks bala
Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients
Keywords: تعاملات دارویی; Polypharmacy; Potentially inappropriate medications; Drug-drug interactions; Geriatric patients; Hematologic malignancy;
Herb-drug interaction of Nisha Amalaki and Curcuminoids with metformin in normal and diabetic condition: A disease system approach
Keywords: تعاملات دارویی; NA; Nisha Amalaki; CE; Curcuminoids; MET; metformin; DDI; drug-drug interactions; HDI; herb-drug interactions; CYPs; cytochrome p450 isoenzymes; IS; internal standard; MWR; Male Wistar rats; STZ; streptozotocin; MNC; mononuclear cells; OCT; organic cation
Biphasic modulation of cAMP levels by the contraceptive nomegestrol acetate. Impact on P-glycoprotein expression and activity in hepatic cells
Keywords: تعاملات دارویی; ABC transporters; Nomegestrol acetate; cAMP; Membrane progesterone receptor; Drug-drug interactions;
Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys
Keywords: تعاملات دارویی; mu opioid receptor agonist; Cannabinoid receptor agonist; Rhesus monkey; Ventilation; Respiration; Drug-drug interactions;
Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy
Keywords: تعاملات دارویی; Hepatitis C virus; Opioid agonist therapy; Drug-drug interactions; Direct acting antivirals; Best practice;
New insights in the in vitro characterisation and molecular modelling of the P-glycoprotein inhibitory promiscuity
Keywords: تعاملات دارویی; ADMET; adsorption, distribution, metabolism, excretion, toxicity; DDIs; drug-drug interactions; NME; new molecular entity; Rh123; rhodamine 123; H33342; Hoechst 33,342; P-gp; P-glycoprotein; P-glycoprotein; Drug-drug interactions; Docking; In vitro; Bindi
Role of the equine CYP3A94, CYP3A95 and CYP3A97 in ketamine metabolism in presence of medetomidine, diazepam and methadone studied by enantioselective capillary electrophoresis
Keywords: تعاملات دارویی; CE; capillary electrophoresis; Clint; intrinsic clearance; CLM; canine liver microsomes; CYP; cytochrome P450 enzymes; D; diazepam; DHNK; 5,6-dehydronorketamine; ELM; equine liver microsomes; HLM; human liver microsomes; HNK; hydroxynorketamine; IST; inte
Different inhibitory effects of azole-containing drugs and pesticides on CYP2C9 polymorphic forms: An in vitro study
Keywords: تعاملات دارویی; CYP2C9; Polymorphism; Azole; Pesticide; Cytochrome b5; Drug-drug interactions;
Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7
Keywords: تعاملات دارویی; Antitumor agent C-1748; Drug-drug interactions; II phase metabolism; Glucuronidation; Enzyme inhibition; UGT;
Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes
Keywords: تعاملات دارویی; Estradiol (PubChem CID: 5757); Chenodeoxycholic acid (PubChem CID: 10133); Serotonin (PubChem CID: 5202); Propofol (PubChem CID: 4943); Zidovudine (PubChem CID: 35370); CYP; cytochrome P450; UGT; UDP-glucuronosyltransferases; DDI; drug-drug interactions;
Inhibition of Organic Anion Transporting Polypeptide 1B1 and 1B3 by Betulinic Acid: Effects of Preincubation and Albumin in the Media
Keywords: تعاملات دارویی; transporters; natural products; drug interactions; drug transport; food interactions; ATV; atorvastatin; BA; betulinic acid; BSA; bovine serum albumin; CysA; cyclosporin A; DCF; 2â²,7â²-dichlorofluorescein; DDIs; drug-drug interactions; DPBS; Dulbecco's
Ligand-dependent modulation of hOCT1 transport reveals discrete ligand binding sites within the substrate translocation channel
Keywords: تعاملات دارویی; OCT1; Organic Cation Transporter 1; hOCT1; human OCT1; HEK; Human Embryonic Kidney; EV; empty vector; MPP+; 1-methyl-4-phenylpyridinium; TEA; tetraethylammonium; CCF; competitive counter flow; TMD; transmembrane domains; CHARMm; Chemistry at Harvard Macro
MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia
Keywords: تعاملات دارویی; Tardive dyskinesia; Metoclopramide; Drug safety; Drug-drug interactions; Drug repurposing; Combination therapy;
Effects of diosmetin on nine cytochrome P450 isoforms, UGTs and three drug transporters in vitro
Keywords: تعاملات دارویی; Diosmetin; Cytochrome P450; UDP-glucuronyltransferases; Hepatic uptake transporters; Drug-drug interactions; CYPs; Cytochrome P450 enzymes; DDI; drug-drug interactions; HDI; herb-drug interactions; HLMs; human liver microsomes; NTCP; Na+-taurocholate cotr
Screening of Eleven Commonly Used Traditional Chinese Medicines for Inhibitory Effects on Human Cytochrome P450 Enzymes
Keywords: تعاملات دارویی; cocktail; cytochrome P450; drug-drug interactions; inhibition; traditional Chinese medicines;
Conduite à tenir en cas d'association d'un alpha-bloquant et d'un inhibiteur puissant du cytochrome 3A4
Keywords: تعاملات دارویی; Alpha-bloquant; Alfuzosine; Tamsulosine; Inhibiteurs du CYP3A4; Interactions médicamenteuses; Adrenergic alpha-1 receptor antagonists; Alfuzosin; Tamsulosin; CYP3A inhibitors; Drug-drug interactions;
Universal efavirenz determination in transport study, rat placenta perfusion and placenta lysate by HPLC-UV
Keywords: تعاملات دارویی; Efavirenz; Drug transporters; Drug-drug interactions; Liquid chromatography; Pharmacokinetics; Stability;
Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay
Keywords: تعاملات دارویی; Cytochrome P450; Drug-drug interactions; Food-drug interactions; Shikonin; Cocktail approach;
Comprehensive assessment of Cucurbitacin E related hepatotoxicity and drug-drug interactions involving CYP3A and P-glycoprotein
Keywords: تعاملات دارویی; Cucurbitacin E; CYP3A; P-glycoprotein; Hepatotoxicity; Drug-drug interactions; CuE; cucurbitacin E; P-gp; p-glycoprotein; Cmax; the maximum serum concentration; AUC; area under the concentration-time curve; CL; clearance; Vd; volume of distribution; t1/2;
In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation
Keywords: تعاملات دارویی; Drug-drug interactions; CYP2D6; Bupropion; Enzyme regulation; In vitro to in vivo extrapolation; AUC; area under plasma concentration time curve; CYP; cytochrome P450; DDI; drug-drug interaction; fm; fraction metabolized; IVIVE; in vitro to in vivo extrap
Steviol, an aglycone of steviol glycoside sweeteners, interacts with the pregnane X (PXR) and aryl hydrocarbon (AHR) receptors in detoxification regulation
Keywords: تعاملات دارویی; Food-drug interactions; Drug metabolism; Nuclear receptors; Steviol; Stevioside; ADI; accepted daily intake; AHR; arylhydrocarbon receptor; CAR; constitutive androstane receptor; CYP; cytochrome P450; DDIs; drug-drug interactions; FDIs; food-drug interact
The New Era of Hepatitis C
Keywords: تعاملات دارویی; Hepatitis C virus; Direct antiviral agents; Cirrhosis; Hepatocellular carcinoma; Liver transplant; Drug-drug interactions; Anti-HCV-positive donors; Waiting list;
Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human
Keywords: تعاملات دارویی; LC-MS/MS; CYP450 probe-drug cocktail; Drug metabolism; Drug-drug interactions; Phenotyping;